Yusuke Toyohara
Exploring foci of
2025-04-07
Clinical characteristics of bowel mucosal invasion in epithelial ovarian cancer
2025-04-07 • Yusuke Toyohara, Atsushi Fusegi, Motoko Kanno, Sachiho Netsu, Terumi Tanigawa, Mayu Yunokawa, Hiroyuki Kanao
<title>Abstract</title> Background Bowel mucosal invasion epithelial ovarian cancer (EOC) is classified as stage IVB disease. The reason for this classification remains unclear, and clinical data on bowel mucosal invasion in EOC should be investigated. Methods We retrospectively reviewed data from patients with stage IVB EOC who presented at our hospital with bowel mucosal invasion between January 2011 and September 2023. Patients with bowel mucosal invasion and other factors associated with IVB EOC were excluded …
Clinical Trial
Inflammatory Bowel Disease
Clinical Chemistry
Irritable Bowel Syndrome
Short Bowel Syndrome
Bowel Obstruction
Maneuvering Characteristics Augmentation System
Clinical Endpoint
Clinical Death
Exploring foci of
2025-12-16
Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma
2025-12-16 • Yusuke Toyohara, Kenbun Sone, Kohei Kumegawa, Yoko Yamamoto, Ryuta Hachijo, Asako Kukita, Ayumi Taguchi, Masako Ikemura, Yuichiro Miyamoto, Michihi...
OTS186935 inhibited double-strand DNA break repair, as evidenced by γH2AX downregulation by ChIP-seq and other assays. Combining OTS186935 with olaparib demonstrated activity resembling synthetic lethality; however, further validation is required before clinical translation.
Hello Muddah, Hello Fadduh (A Letter From Camp)
So Far From God
Tales From Planet Earth
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Suicide Notes From Beautiful Girls
From Out Of Nowhere (Jeff Lynne's Elo Album)
Exploring foci of
2024-01-30
Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification
2024-01-30 • Futaba Inoue, Kenbun Sone, Kohei Kumegawa, Ryuta Hachijo, Eri Suzuki, Saki Tanimoto, Natsumi Tsuboyama, Kosuke Kato, Yusuke Toyohara, Yu Takahashi,...
Histone modification, a major epigenetic mechanism regulating gene expression through chromatin remodeling, introduces dynamic changes in chromatin architecture. Protein arginine methyltransferase 6 (PRMT6) is overexpressed in various types of cancer, including prostate, lung and endometrial cancer (EC). Epigenome regulates the expression of endogenous retrovirus (ERV), which activates interferon signaling related to cancer. The antitumor effects of PRMT6 inhibition and the role of PRMT6 in EC were investigated, u…
Competitive Inhibition
Cd40 (Protein)
Protein Dimer
Whey Protein
Protein Kinase B
Soy Protein
Sonic Hedgehog Protein
G Protein
Serum Protein Electrophoresis
Exploring foci of
2024-12-19
BET inhibitor JQ1 induces apoptosis of ovarian and endometrial endometrioid carcinoma cells by downregulating <i>c‑Myc</i>
2024-12-19 • Saki Tanimoto, Kenbun Sone, Yuri Jonouchi, Ryuta Hachijo, Eri Suzuki, Natsumi Tsuboyama, Yusuke Toyohara, Futaba Inoue, Harunori Honjoh, Tomohiko F...
Although ovarian endometrioid carcinoma (OEC), frequently associated with endometrial endometrioid carcinoma (EEC), is often diagnosed at an early stage, the prognosis remains poor. The development of new, effective drugs to target these cancers is highly desirable. The bromodomain and extra-terminal domain (BET) family proteins serve a role in regulating transcription by recognizing histone acetylation, which is implicated in several types of cancer. BET inhibitors have been reported as promising cancer drugs. Th…
Serotonin–Norepinephrine Reuptake Inhibitor
Selective Serotonin Reuptake Inhibitor
Phosphodiesterase Inhibitor
Acetylcholinesterase Inhibitor
Plasminogen Activator Inhibitor-1
Monoamine Oxidase Inhibitor
Apoptosis
Dopamine Reuptake Inhibitor
Phosphodiesterase-4 Inhibitor
Exploring foci of
2024-02-07
Synthetic lethality from the combination of a histone methyltransferase, SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma
2024-02-07 • Yusuke Toyohara, Kenbun Sone, Kohei Kumegawa, Yoko Yamamoto, Ryuta Hachijo, Saki Tanimoto, Futaba Inoue, Asako Kukita, Ayumi Taguchi, Masako Ikemur...
<title>Abstract</title> <bold>Background:</bold> Uterine leiomyosarcoma (uLMS) has a poor prognosis owing to its high recurrence rate and resistance to chemotherapy. Therefore, novel therapeutic targets for uLMS need to be discovered. SUV39H2 is a histone methyltransferase that promotes the repair of double-stranded DNA breaks by recruiting phosphorylated H2AX (γH2AX). In this study, we investigated the potential therapeutic targets of SUV39H2 in uLMS and the mechanism of synthetic lethality between PARP inhibitor…
Hello Muddah, Hello Fadduh (A Letter From Camp)
So Far From God
Tales From Planet Earth
Plan 9 From Outer Space
Away From Her
The Girl From Everywhere
The View From Saturday
Suicide Notes From Beautiful Girls
From Out Of Nowhere (Jeff Lynne's Elo Album)